Atria Investments LLC Repligen Corp Transaction History
Atria Investments LLC
- $7.56 Billion
- Q3 2024
A detailed history of Atria Investments LLC transactions in Repligen Corp stock. As of the latest transaction made, Atria Investments LLC holds 3,202 shares of RGEN stock, worth $511,903. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,202
Previous 1,907
67.91%
Holding current value
$511,903
Previous $240,000
98.33%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
476Shares Held
54.5MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.21 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.02 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$806 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$260 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$227 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.87B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....